Autologous fibroblasts to treat deep and complicated leg ulcers in diabetic patients

Wound Repair and Regeneration

Volumn 15, Issue 1, 2007, Pages 35-38

  Cavallini, Marco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC FOOT; FEMALE; FIBROBLAST; GRANULATION TISSUE; HEART INFARCTION; HUMAN; LEG ULCER; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SKIN AUTOGRAFT; STAPHYLOCOCCUS AUREUS; STEROID THERAPY; ULCER HEALING; WOUND HEALING;

AGED; DIABETIC FOOT; FEMALE; FIBROBLASTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; SURGICAL MESH; TREATMENT OUTCOME; WOUND INFECTION;

EID: 33846410271     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2006.00182.x     Document Type: Article

References (11)

1. American Diabetes Association. Foot care in patients with diabetes mellitus (Position statement). Diabetes Care 1996; 19 (Suppl. 1): S23-4.
2. Wagner FW. Orthopedic rehabilitation of the dysvascular limb. Ortho Clin North Am 1978; 9: 325-49.
3. Barone EJ, Yager DR, Pozez AL, Olutoye OO, Crossland MC, Diegelmann RF, Cohen IK. Interleukin-1alpha and collagenase activity are elevated in chronic wounds. Plast Reconstr Surg 1998; 102: 1023-7.
4. Yager DR, Nwomeh BC. The proteolytic environment of chronic wounds. Wound Repair Regen 1999; 7: 433-41.
5. Agren MS, Steenfos HH, Dabelsteen S, Hanesen JB, Dabelsteen E. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcerage dependent. J Invest Dermatol 1999; 112: 463-9.
6. Vande Berg JS, Smith PD, Haywood-Reid PL, Munson AB, Soules KA, Robson MC. Dynamic forces in the cell cycle affecting fibroblasts in pressure ulcers. Wound Repair Regen 2001; 9: 19-27.
7. Wieman TJand the Becaplermin Gel Study Group. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Am J Surg 1998; 176 (Suppl. 2A): 74S-9S.
8. Marston WA, Hanft J, Norwood P, Pollak RDermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003; 26: 1701-5.
9. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001; 24: 290-5.
10. Caravaggi C, De Giglio R, Pritelli C, Sommaria M, Dalla Noce S, Faglia E, Mantero M, Clerici G, Fratino P, Dalla Paola L, Mariani G, Mingardi R, Morabito A. HYAFF 1-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers. Diabetes Care 2003; 26: 2853-9.
11. Uccioli L.TissueTech Autograph System Italian Study Group. A clinical investigation on the characteristics and outcomes of treating chronic lower extremity wounds using the tissuetech autograft system. Int J Low Extrem Wounds 2003; 2: 140-51.